The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Nuveen International Eq Idx Premier TRIPX
- NAV / 1-Day Return 24.34 / +0.50 %
- Total Assets 26.7 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.200%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 2.64%
- Turnover 8%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis TRIPX
Will TRIPX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 2.46 | 645.4 Mil | Healthcare |
ASML Holding NV | 2.11 | 555.4 Mil | Technology |
Msci Eafe Sep24 Ifus 20240920 | 1.75 | 460.4 Mil | — |
Nestle SA | 1.54 | 403.8 Mil | Consumer Defensive |
AstraZeneca PLC | 1.40 | 367.6 Mil | Healthcare |
Shell PLC | 1.33 | 348.6 Mil | Energy |
Roche Holding AG | 1.29 | 339.5 Mil | Healthcare |
SAP SE | 1.25 | 329.5 Mil | Technology |
Novartis AG Registered Shares | 1.25 | 328.5 Mil | Healthcare |
Toyota Motor Corp | 1.16 | 304.0 Mil | Consumer Cyclical |